BIRAC announces call for proposals in biosimilar product development shared facilities for biotherapeutics development and novel cell line development
The vision of the Program is to enable and nurture an ecosystem for preparing India’s technological and product development capabilities in biopharmaceuticals.
Seed companies hail Supreme Court’s order on Monsanto Bt cotton patent case
The Indian seed industry bodieshailed the Supreme Court’s decision to set aside the Delhi High Court orderthat had invalidated the patent right of US-based agro major Monsanto Technology over BT cotton seeds for its Bollgard technology.
Lok Sabha passes The DNA Technology Regulation Bill – 2019
The Bill has been formulated recognizing the need for regulation of the use and application of Deoxyribonucleic Acid (DNA) technology, for establishing identity of missing persons, victims, offenders, under trials and unknown deceased persons.
Genomic chips developed by Brazil to be implemented in genomic selection for India’s indigenous breeds
Union Minister of Agriculture and Farmers’ Welfare Radha Mohan Singh meets 5-member delegation from Brazil. Minister Singh has informed that in the latest development in breeding techniques, four animal breeding Centers of Excellence (COE) are being set up for ETT, IVF, sex-sorted semen, genomics and training of skilled manpower.
Lilly to acquire Loxo Oncology for 8 billion dollar
The acquisition would be the largest and latest in a series of transactions Lilly has conducted to broaden its cancer treatment efforts with externally sourced opportunities for first-in-class and best-in-class therapies.
PAREXEL launches new dedicated biotech division in USA to support emerging companies
Led by James Anthony, Global Head of Biotech, and Graciela Racaro, Global Head of Biotech Operations, the division will help emerging companies minimize complexity, reduce costs, and accelerate timelines.
Nobel Laureates inaugurate Children Science Congress at Indian Science Congress 2019
As a part of the five-day Indian Science Congress, Rashtriya Kishore Vaigyanik Sammelan (Children Science Congress) was inaugurated in Jalandhar by Nobel Laureates Avram Hershko from Israel and F.Duncan M.Haldane from USA.
Alphabet’s Verily raises 1 billion dollar investment to fund growth and innovation
The capital raised will support growth in key strategic areas, including investments in strategic partnerships, global business development opportunities, and potential acquisitions.
Boehringer Ingelheim partners with Science 37 for virtual clinical trials
Boehringer Ingelheim collaborates with Science 37 to accelerate the clinical development of new therapies worldwide; Science 37’s technology enables patients to remotely participate in clinical studies
Cabinet approves restructuring of National Health Agency as National Health Authority
With this approval, the existing society "National Health Agency" has been dissolved and will be replaced by National Health Authority as an attached office to Ministry of Health & Family Welfare.
BITS BIRAC BioNEST Incubator for Startups and Entrepreneurs in Healthcare and Environment to be established in Goa
The 3,500 sq ft facility will focus on helping startups in the health and environment sectors to find innovative solutions to issues in these areas.
BIRAC announces 14th call for proposals under the Biotechnology Ignition Grant Big Scheme
BIRAC has invited proposals from biotech Start-ups and Individual Entrepreneurs with innovative ideas having a potential for commercialization.Grant-in-aid up-to INR 50 lakhs for a maximum period of 18 months.
Department of Pharmaceuticals lays down fresh formulation content norms
With an aim to push ‘Make in India’ in the pharmaceuticals sector, the Department of Pharmaceuticals (DoP) has decided on the content of formulations that are manufactured and for those that are not manufactured in India.
Cabinet apprised of two biotechnology related bilateral MoUs between Cuba and Korea
The MoUs signed with Cuba and Korea respectively, are in the agreed areas of collaboration and objectives in the field of Science & Technology, wherever the expertise in these areas exist in the country.
Vedanta Biosciences raises 27 million dollar to advance clinical pipeline of microbiome-derived product candidates
Participants in the fund include the Bill & Melinda Gates Foundation, Bristol-Myers Squibb, Rock Springs Capital, Invesco Asset Management, Seventure, and PureTech Health
Dr. Srinubabu Gedela receives ‘Champions of Change’ Award from Vice President of India
The award was given to Dr Srinubabu Gedela for his relentless work and contribution in various social and healthcare services, and for his involvement in sharing healthcare and agricultural information to remotest corners of India.
Sun Pharma’s subsidiary DUSA Pharmagets preliminary injunctive relief prohibiting Biofrontera from using its trade secrets
DUSA PharmaceuticalsInc., the wholly owned subsidiary of Sun Pharmaceutical Industries Ltd,has announced that DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera
USA UK Ireland scientist partner AMTZ to further biomaterials research
At a recently held event, AMTZ and KIHT brought the bio-materials community together and exchanged ideas on how the entire ecosystem can promote indigenous products researched at Indian institutions of merit.
China’s HitGen Bayer enter DNA-encoded library-basedresearch collaboration
“Our research and development (R&D) platforms are supplemented by what we call an ‘open innovation’ model,” said Axel Trautwein, Head of Small Molecules, Crop Science division of Bayer. “HitGen’s experience in DNA-encoded chemistry fits that model well, and we look forward to using their advanced technology platform to develop solutions that help farmers control existing crop threats and get ahead of emerging ones.”
Propanc Biopharma’s cancer treatment granted patent in India
“Building a robust patent portfolio has been a top priority in driving our drug development technology forward. Adding India to the growing list of countries where we have been granted patents reflects the strength of our growing IP portfolio for PRP,” said James Nathanielsz, Propanc’s Chief Executive Officer.
Bristol-Myers Squibb and Boston Medical Center collaborate to investigate markers of immuno-oncology response and resistance
The comprehensive, multi-dimensional study will place an emphasis on uncovering mechanisms associated with lack of response to Immuno-Oncology (I-O) therapies
Serum Institute’s partner NeuClone develops mAb for breast cancer indication
NeuClone's Perjeta (pertuzumab) biosimilar is partnered with Serum Institute of India (Serum). Under the partnership, NeuClone and Serum are developing ten biosimilars for global markets.
Prime Minister Narendra Modi inaugurates the Partners Forum - 2018
Prime Minister Narendra Modi inaugurated the Partners’ Forum, 2018, in New Delhi on December 12th. He also released the coffee table book ‘Proven Paths’, a compendium of 36 best practices in maternal, child and adolescent health, at the inaugural ceremony.
A Star in deal with AUM Biosciences and One Biomed
In two separate dealings, AUM Biosciences has licensed its first novel, highly selective anti-cancer drug from A*STAR's Experimental Therapeutics Centre (ETC) and A*STAR's Institute of Microelectronics (IME) and One BioMed have launched a S$9 million joint lab.
Dr. Ashis Kumar Sen conferred Swarnajayanti Fellowship for his work on cancer and dengue detection
Dr. Ashis Kumar Sen is one among the three Professors to receive this Fellowship in Engineering Sciences discipline from the entire country. His main research interests are in the areas of microfluidics based interfacial phenomena and healthcare diagnostics.